Barnes & Thornburg Adds Intellectual Property Litigator in Atlanta
Barnes & Thornburg LLP has added David Kelly as a partner in the Intellectual Property Department in the firm’s Atlanta office. He joins from Hunton & Williams LLP, where he chaired that firm’s Life Sciences practice.
In a release, the firm said Kelly is a patent litigator who represents clients on a variety of intellectual property matters in the life sciences and technology industries, including medical device, pharmaceutical and molecular diagnostic, as well as synthetic biology and biotech companies. Kelly’s experience extends to managing IP due diligence and international patent prosecution dockets and acting as trial, appellate and inter partes review counsel in front of the U.S. Patent and Trademark Office and federal district courts.
“We’re excited to add David to our IP bench in Atlanta,” said Stuart Johnson, managing partner of the firm’s Atlanta office. “Our region’s tech ecosytem is one of the fastest growing in the U.S., which makes David’s medical and tech-focused legal practice directly applicable to the strategic opportunities we see in our region and elsewhere.”
On the trial side, Kelly has been lead trial lawyer on numerous cases involving patent infringement, trade secret misappropriation, and false advertising. He has deep knowledge and experience at every stage of litigation, including transferring cases to different venues, dismissing claims, obtaining summary judgement of patent validity and invalidity, obtaining sanctions against competitors, and winning appeals for both patent owners and accused infringers.
“David is a talented IP litigator and counselor to his clients,” said Julia Gard, chair of Barnes & Thornburg’s Intellectual Property Department. “His tactful ability and experience in successfully litigating high-stakes, multi-million dollar patent infringement cases will be a great advantage to our national practice visibility. His wide-ranging knowledge and impressive skillset in court will be a great benefit to our clients.”
Kelly received his J.D. from the University of California-Davis, and a double B.S. from the University of Georgia. He also completed two years of graduate coursework in microbiology and immunology at the University of North Carolina at Chapel Hill, where he worked in a well-known virology laboratory studying Epstein-Barr virus.
